450 likes | 595 Views
Facts on Elderly Populations . persons 65 years or older--numbered 34.5 million in 1999. 12.7% of the U.S. population, about one in every eight Americans Since 1900, the percentage of Americans 65 has more than tripled (4.1% in 1900 to 12.7%) older population itself is getting older ) By 2030, it
E N D
1. Screening Elderly Syed I. Nabi, MD
Resident
MHRI
2. Facts on Elderly Populations persons 65 years or older--numbered 34.5 million in 1999. 12.7% of the U.S. population, about one in every eight Americans
Since 1900, the percentage of Americans 65+ has more than tripled (4.1% in 1900 to 12.7%)
older population itself is getting older ) By 2030, it will double to 70 million older persons,
5. Commonly screened conditions: DM
HTN
ANEMIA
CANCERS
CAS
LIPID
DEMENTIA
6. But I forget……..!!!
8. Screening Guideline Trends… GENERAL TREND ORGANIZATION WITH SPECIALITY ARE MORE AGGRESSIVE THAN ORGANIZATION COVERING BROADER POPULATIONS E.G. AAFP/ USPSTF
9. When and How???
19. ACAS (Asymptomatic Carotid Atherosclerosis Study) JAMA 1995;5:
5 year Risk of Ipsilateral Stroke, operative stroke, and Death was ~5% with CEA (Carotid endarterectomy ) vs. 11% in control group
More benefit in men than women
Cost-effectiveness of targeted screening and surgery for high grade carotid artery stenosis is ~ $43,000 per QALY (Quality Adjusted Life Year)
Prevalence of ICAS (Internal Carotid Artery Stenosis) of <70% tends to increase as follows:
Thus lowest in patients with ONLY RISK Factors
Intermediate in patients with MI and Angina
Highest in patients with PAD and AAA
ACST (Asymptomatic Carotid Surgery Trial): LANCET 2004
Absolute Risk reduction for stroke or death was 5.4% at 5 years with significant benefit for women
CARESS Trial (Clopidogrel & ASA for Reduction of Emboli in Symptomatic Carotid Stenosis) Circulation 2005 May
Clopidogrel & ASA more affective than ASA alone in reducing asymptomatic embolization in RECENTLY SYMPTOMATIC >50% CAS
31. CANCERS??? MALE
ORAL
THYROID
LUNG
GASTRIC
LIVER
PANCREATIC
COLORECTAL
BLADDER
PROSTATE
TESTICULAR
SKIN FEMALE
ORAL
THYROID
BREAST
LUNG
GASTRIC
LIVER
PANCREATIC
COLORECTAL
BLADDER
OVARIAN
CERIVICAL
ENDOMETRIAL
SKIN